MedPath

Efficacy of Laser Versus Cryotherapy in the Treatment of Warts

Not Applicable
Completed
Conditions
Warts
Interventions
Other: Cryotherapy
Other: laser
Registration Number
NCT01808443
Lead Sponsor
The 306 Hospital of People's Liberation Army
Brief Summary

The purpose of this study is to test the efficacy of laser versus cryotherapy on the treatment of warts

Detailed Description

Cutaneous warts were a common skin diseases caused by human papilloma virus (HPV) infection. Although warts may spontaneously resolve, many patients seek for treatment for various reasons. There are many kinds of treatments for cutaneous warts, including salicylic acid, cryotherapy, laser, etc. A recent high quality RCT confirmed that the cure rate of topical salicylic acid and frozen has no difference at six months, but the efficacy of laser versus cryotherapy on the treatment of warts remains unclear. Therefore, we designed a randomized controlled trial to test the efficacy of laser versus cryotherapy on the treatment of warts.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients have cutaneous warts, including common warts(d≥1cm or n≥5 ), plantar warts, periungual warts, mosaic warts, which are suitable for cryotherapy and laser treatment .
  • patients aged eighting years and over, who have junior school degree or above
Exclusion Criteria
  • Patients who have more than 20 warts
  • Patients who are currently participating in another trial for the treatment of their warts
  • Patients who took immunosuppressant drugs such as oral corticosteroids within the past three months.
  • Patients who are pregnant or ready for pregnancies or breast-feeding.
  • Patients who have impaired healing eg due to diabetes, vascular disease, vitamin A deficiency, hyperthyroidism and hypothyroidism.
  • Patients who have autoimmune diseases, eg SLE, dermatomyositis, scleroderma and other diseases .
  • Patients who have cold intolerance, eg cold urticaria, cryoglobulinaemia, cold agglutinin syndrome, Raynaud's syndrome.
  • Patients who have local injections intolerance.
  • Patients who have local hypoesthesia .
  • Patients who can not tolerate cryotherapy or laser treatment for their own reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CryotherapyCryotherapyCryotherapy, at most 4 times
laserlaserlaser, at most 4 times
Primary Outcome Measures
NameTimeMethod
cure rateCure rate will be calculated at 16 weeks and 6 months from the first treatment

Warts was considered cured if they was no longer visible and could not be palpated anymore by hand. Assessment of whether or not cured was performed on site by a senior dermatologist

Secondary Outcome Measures
NameTimeMethod
effective rateEffective rate will be calculated at 16 weeks from the first treatment

Effective assessment is performed by a senior dermatologist.

recurrence rateRecurrence rate will be calculated at 12 months from the first treatment

A wart was considered recurrence if there are abnormalities or palpated foreign body in the original place.

average cure daysAverage cure days will be calculated at 6 months from the first treatment

Cure days was defined as the period from the first treatment until the date of clearance.

patient satisfactionPatient satisfactionwill be assessed within 3-4 weeks after each treatment

on a five-point scale, from 'very satisfied' to 'very satisfied'

treatment costsTreatment costs will be recorded within 10 minutes after each treatment

record the cost after each treatment

relationship between HPV type and curative effectRelationship between HPV type and curative effect will be analyzed at 16 weeks and 6 months from the first treatment

take a small amount of cutaneous warts lesions and extract HPV DNA before treatment

side effectsSide effects will be assessed within 3-4 weeks after each treatment

including pain, swelling, blisters, blood blisters, bruising, bleeding,scarring, hypopigmentation, hyperpigmentation.

pain intensityPain intensity will be assessed within 3-4 weeks after each treatment

on a scale of 0-10, where 0 is no pain and 10 is extremely painful

Trial Locations

Locations (1)

The 306 Hospital of PLA

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath